BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35373379)

  • 1. Human Metabotropic Glutamate Receptor 5 Antibodies Alter Receptor Levels and Behavior in Mice.
    Maudes E; Mannara F; García-Serra A; Radosevic M; Mellado A; Serafim AB; Planagumà J; Sabater L; Dalmau J; Spatola M
    Ann Neurol; 2022 Jul; 92(1):81-86. PubMed ID: 35373379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex.
    Joubert B; Petit-Pedrol M; Planagumà J; Mannara F; Radosevic M; Marsal M; Maudes E; García-Serra A; Aguilar E; Andrés-Bilbé A; Gasull X; Loza-Alvarez P; Sabater L; Rosenfeld MR; Dalmau J
    Ann Neurol; 2022 Jun; 91(6):801-813. PubMed ID: 35253937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.
    Lancaster E; Martinez-Hernandez E; Titulaer MJ; Boulos M; Weaver S; Antoine JC; Liebers E; Kornblum C; Bien CG; Honnorat J; Wong S; Xu J; Contractor A; Balice-Gordon R; Dalmau J
    Neurology; 2011 Nov; 77(18):1698-701. PubMed ID: 22013185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.
    Spatola M; Sabater L; Planagumà J; Martínez-Hernandez E; Armangué T; Prüss H; Iizuka T; Caparó Oblitas RL; Antoine JC; Li R; Heaney N; Tubridy N; Munteis Olivas E; Rosenfeld MR; Graus F; Dalmau J
    Neurology; 2018 May; 90(22):e1964-e1972. PubMed ID: 29703767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid.
    Guevara C; Farias G; Silva-Rosas C; Alarcon P; Abudinen G; Espinoza J; Caro A; Angus-Leppan H; de Grazia J
    Front Immunol; 2018; 9():2568. PubMed ID: 30455705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin Lymphoma Cell Lines and Tissues Express mGluR5: A Potential Link to Ophelia Syndrome and Paraneoplastic Neurological Disease.
    Schnell S; Knierim E; Bittigau P; Kreye J; Hauptmann K; Hundsdoerfer P; Morales-Gonzalez S; Schuelke M; Nikolaus M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.
    Planagumà J; Leypoldt F; Mannara F; Gutiérrez-Cuesta J; Martín-García E; Aguilar E; Titulaer MJ; Petit-Pedrol M; Jain A; Balice-Gordon R; Lakadamyali M; Graus F; Maldonado R; Dalmau J
    Brain; 2015 Jan; 138(Pt 1):94-109. PubMed ID: 25392198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice.
    García-Serra A; Radosevic M; Ríos J; Aguilar E; Maudes E; Landa J; Sabater L; Martinez-Hernandez E; Planagumà J; Dalmau J
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature.
    Guo K; Liu X; Gong X; Li A; Liu Y; Li X; Zhou D; Hong Z
    Front Immunol; 2023; 14():1146536. PubMed ID: 37025999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
    Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
    Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.
    Petit-Pedrol M; Sell J; Planagumà J; Mannara F; Radosevic M; Haselmann H; Ceanga M; Sabater L; Spatola M; Soto D; Gasull X; Dalmau J; Geis C
    Brain; 2018 Nov; 141(11):3144-3159. PubMed ID: 30346486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDAR Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice.
    Carceles-Cordon M; Mannara F; Aguilar E; Castellanos A; Planagumà J; Dalmau J
    Ann Neurol; 2020 Sep; 88(3):603-613. PubMed ID: 32583480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice.
    Radosevic M; Planagumà J; Mannara F; Mellado A; Aguilar E; Sabater L; Landa J; García-Serra A; Maudes E; Gasull X; Lewis M; Dalmau J
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34903638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
    Spatola M; Petit Pedrol M; Maudes E; Simabukuro M; Muñiz-Castrillo S; Pinto AL; Wandinger KP; Spiegler J; Schramm P; Dutra LA; Iorio R; Kornblum C; Bien CG; Höftberger R; Leypoldt F; Titulaer MJ; Sillevis Smitt P; Honnorat J; Rosenfeld MR; Graus F; Dalmau J
    Neurology; 2020 Dec; 95(22):e3012-e3025. PubMed ID: 32928978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Guillain-Barré Syndrome Characterized by Severe Headache Associated With Metabotropic Glutamate Receptor 5 Antibody.
    Yan W; Zhao C; Zhang H; Hu Z; Wang C
    Front Immunol; 2022; 13():808131. PubMed ID: 35386694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental transfer of NMDAR antibodies causes reversible alterations in mice.
    García-Serra A; Radosevic M; Pupak A; Brito V; Ríos J; Aguilar E; Maudes E; Ariño H; Spatola M; Mannara F; Pedreño M; Joubert B; Ginés S; Planagumà J; Dalmau J
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33172961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Anti-mGluR5 antibody-negative Ophelia syndrome with failed lymph node biopsy due to steroid therapy.
    Sanpei Y; Miura M; Funasaka H; Hanazono A; Kamada S; Sugawara M
    Front Immunol; 2023; 14():1188154. PubMed ID: 38162652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS syndromes associated with antibodies against metabotropic receptors.
    Lancaster E
    Curr Opin Neurol; 2017 Jun; 30(3):354-360. PubMed ID: 28306571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.
    Planagumà J; Haselmann H; Mannara F; Petit-Pedrol M; Grünewald B; Aguilar E; Röpke L; Martín-García E; Titulaer MJ; Jercog P; Graus F; Maldonado R; Geis C; Dalmau J
    Ann Neurol; 2016 Sep; 80(3):388-400. PubMed ID: 27399303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.